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Abstract
Ab initio conformational analysis has been carried out on 3-mercapto-propanamide, (R)- and (S)-2-methyl-3-mercapto-
propanamide as well as theirS-deprotonated conjugate basis. They were carried out at the HF/3-21G level of theory. The
topology of the conformational potential energy surfaces and hypersurfaces have been analysed.q 2000 Elsevier Science B.V.
All rights reserved.
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1. Introduction
Captopril [1] an effective antihypertensive drug
[1–4] is a relatively small molecule which may be
in its biologically active dianion [1b] or neutral
form [1a]. It has several functional groups and
the molecule may assume numerous stable conforma-
tions. Consequently, captopril [1] can interact regio
and stereospecifically with various functional groups
present at the active site of the angiotensin converting



















Since no X-ray structure of ACE is available one
does not know the stereochemical separations of the
various sites of the enzyme, involved in the action
mechanism. Captopril as an ACE-inhibitor may be
used as a “molecular calliper” to estimate the upper
and lower bound values for the separationd shown in
Fig. 1.
Captopril has been studied [5] by a “classical poten-
tial energy” force field type method as early as 1985.
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Subsequently Hillier et al. [6] carried out AM1
computations on this molecule in 1991. This was
followed by Luke in 1994. Luke [7] also reported
[8] AM1 calculations on the demethylated analogue
of captopril in 1995. As far as it can be ascertained no
ab initio calculations have been reported as yet on
captopril.
2. Method
Ab initio computations have been carried out at the
HF/3-21G level of theory, using theGaussian 94
software [9].
3. Results and discussion
Captopril poses a non-trivial multidimensional
conformational problem. One of the conformational
intricacies is associated with the five-member ring of
the proline moiety. The –CO–NH, moiety may be of
cisor transconfigurations. The five-member ring may
be in a number of non-planar conformations. Finally
the –COOH moiety of [1a] could assume three





































































Fig. 2. Expected conformations (top) and computed relative ener-






























































































Fig. 3. Expected conformations (top) and computed relative ener-
gies,DE (kcal/mol) (bottom) ofR andSenantiomers ofS-deproto-
nated 2-methyl-3-mercapto-propanamide structures.
conformations (g1, a, g2) leading togL, eL, andaL
peptide foldings.
The other conformational variations of captopril [1]
are residing in the flexible open chain which may be
represented as 3-mercapto propanamide or its neutral


















In these structures, the five member ring is omitted
with respect to [1] and the hydrogen atoms are
attached to the amide nitrogen.
Compounds [2a] and [2b] are also missing the
methyl group at thea-carbon (i.e. at C2) with respect
to [1]. If that methyl group is included then two enan-
tiomers may be generated, (S)-2-methyl-3-mercapto-
propanamide [3a] and its conjugate base [3b] as well
as (R)-2-methyl-3-mercapto-propanamide [4a] and its
conjugate base [4b].
Consequently, it seemed prudent to study the
fragments [3b] and [5] of captopril [1] preferably
related to its biologically active dianionic form
[1b]. A derivative of [5], N-formyl-l-prolinamide
[6] has already been studied [10] in a preliminary
fashion.
The S-deprotonated forms of 3-mercapto-propan-
amide [2b] and (S)-2-methyl-3-mercapto-propan-
amide [3b] as well as and (R)-2-methyl-3-mercapto-
propanamide [4b] have been studied by the ab initio
method at the HF/3-21G levels of theory. The results
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Table 1
Computed conformational characteristics ofS-deprotonated 3-mercapto-propanamide optimised at the HF/3-21G level of theory
f c v Etotal DE
g1g1 Not found
g1a Not found
g1g2 78.79 246.17 2177.29 2640.6483579 0.00
ag1 2175.19 66.76 175.02 2640.6356826 7.95
aa 2180.00 179.98 2179.98 2640.6313114 10.70
ag2 175.19 266.75 2175.02 2640.6356825 7.95





































for [2b] are shown in Fig. 2 and Table 1. It is inter-
esting to note that the four annihilated minima (g1g1,
g1a, g2a, g2g2) correspond to the same four confor-
mers annihilated in N-formyl-glycin-amide. In
peptides (c.f. [7]) such an annihilation is traditionally
rationalised [11] in terms of dipole/dipole repulsion.
The orientation at the bond moments in [7] and [8]
seem to be analogous if not quite identical.
The introduction of methyl group at thea-carbon
upsets the previous dipole/dipole repulsion [8] to such
an extent [9] that another minimum (a, a) was anni-
hilated. The results are shown in Fig. 3 and Table 2,
for both theS- and R-enantiomers of [3b] and [4b],
respectively.
Considering the neutral forms of 3-mercapto-
propanamide and theR- and S-enantiomers of 2-
methyl-3-mercapto-propanamide one may antici-
pate some change due to the fact that the H–S
bond moment will dominate over the C–S bond
moment. These may be seen by comparing [8],
[10] and [11].
Since in [10] the H–S bond moment is further out
than the C–S bond moment in [8], less repulsion is
anticipated. Indeed, this is the case as shown in Fig. 4
and summarised in Table 3.
In the case of the 2-methylated compound [11] the
introduction of the Me-group does not make any
difference for theanti-oriented S–H conformation
u  1808 as may be seen in Fig. 5. However, it
allows more minima for theu  g1 and u  g2
conformation as shown in Fig. 5 and in Tables 4 and 5.
The other fragment of captopril contains a proline
residue. As discussed before such a residue could be
studied in the form ofN-formyl-prolinate [5]. So far
we have investigated the conformational behaviour of
N-formyl-prolinamide [6]. As it has to be emphasised
that the five-member ring in the proline residue [12]
allows the variablef to be in the vicinity ofg2 and
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Table 2
Computed conformational characteristics of theR- andS-enantiomers ofS-deprotonated 2-methyl-3-mercapto-propanamide optimised at HF/3-
21G level of theory




g1g2 79.39 249.48 2174.38 65.92 2679.4712174 0.00
ag1 170.75 51.27 174.45 61.01 2679.4575281 8.59
aa Not found
ag2 165.45 273.57 2175.37 54.73 2679.459622 7.28






g1g2 73.78 246.45 2174.58 269.34 2679.4688851 1.46
ag1 2165.43 73.57 175.31 254.69 2679.4596221 7.28
aa Not found
ag2 2170.81 251.50 2174.41 261.16 2679.4575282 8.59
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Table 3
Computed conformational characteristics of the 3-mercapto-propanamide optimised at HF/3-21G level of theory
u f c v x Etotal DE DDE
g1g1g1 59.62 54.85 56.78 179.12 64.63 2680.0077715 3.71 4.96
g1g1a 75.46 70.88 2144.73 2175.96 59.04 2680.0124754 0.76 2.01
g1g1g2 71.24 81.89 264.46 2177.07 62.42 2680.0118538 1.15 2.40
g1ag1 81.75 169.72 66.10 2178.03 68.19 2680.0074814 3.89 5.15
g1aa 86.80 175.44 2159.35 2177.50 61.92 2680.0118794 1.13 2.39
g1ag2 81.05 170.72 282.77 176.21 56.72 2680.0113095 1.49 2.74
g1g2g1 Not found
g1g2a 70.57 270.11 2173.72 2177.63 61.04 2680.0136855 0.00 1.25
g1g2g2 43.64 268.84 289.11 178.25 53.86 2680.0107768 1.83 3.08
ag1g1 179.46 61.49 57.67 179.87 65.42 2680.0056264 3.69 6.31
ag1a Not found
ag1g2 Not found
aag1 2167.67 172.23 65.53 2177.61 67.04 2680.0071222 2.75 5.37
aaa 2175.46 172.88 2164.66 2177.59 59.84 2680.0115057 0.00 2.62
aag2 178.94 178.94 282.57 176.34 53.19 2680.0103653 0.72 3.34
ag2g1 158.71 283.27 47.96 2178.89 62.74 2680.0074613 2.54 5.16
ag2a Not found
ag2g2 2179.15 260.34 267.24 2179.15 58.16 2680.0072888 2.65 5.27
g2g1g1 267.17 60.69 51.17 2174.96 64.34 2680.0078444 4.92 4.92
g2g1a 275.82 68.03 2164.42 2176.67 60.54 2680.0156812 0.00 0.00
g2g1g2 Not found
g2ag1 268.95 170.46 63.92 2177.96 64.23 2680.0089084 4.25 4.25
g2aa 272.75 174.08 2164.51 2178.44 58.36 2680.0123034 2.12 2.12
g2ag2 268.76 173.93 285.69 176.52 52.14 2680.0109917 2.94 2.94
g2g2g1 277.18 277.25 59.64 177.16 62.88 2680.0086255 4.43 4.43
g2g2a 299.88 268.03 174.57 2178.75 56.18 2680.0088266 4.30 4.30
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θ = g+ θ = a θ = g-
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Table 4
Computed conformational characteristics of the (S)-2-methyl-3-mercapto-propanamide optimised at HF/3-21G level of theory
u f c v x Etotal DE DDE
g1g1g1 70.44 55.21 61.78 2176.63 256.73 2680.0087301 4.36 4.36
g1g1a 99.80 68.03 2174.67 178.80 56.19 2680.0088266 4.30 4.30
g1g1g2 77.26 77.29 259.64 2177.17 262.86 2680.0086256 4.43 4.43
g1ag1 68.76 2173.93 85.69 2176.52 252.14 2680.0109917 2.94 2.94
g1aa 72.65 2174.10 164.53 178.40 258.38 2680.0123034 2.12 2.12
g1ag2 68.95 2170.46 263.92 177.96 264.23 2680.0089084 4.25 4.25
g1g2g1 Not found
g1g2a 75.80 267.97 164.41 176.65 260.73 2680.0156813 0.00 0.00
g1g2g2 67.12 260.71 251.27 174.93 264.47 2680.0078445 4.92 4.92
ag1g1 2180.85 60.34 67.24 2177.04 258.16 2680.0072888 2.65 5.27
ag1a Not found
ag1g2 2158.71 83.27 247.96 178.89 262.74 2680.0074613 2.54 5.16
aag1 2178.94 2169.07 82.53 2176.35 253.18 2680.0103653 0.72 3.34
aaa 175.51 2172.86 164.66 177.54 259.84 2680.0115057 0.00 2.62
aag2 2192.28 2172.20 265.48 177.62 266.91 2680.0071224 2.75 5.37
ag2g1 162.418 289.84 53.79 2179.12 264.44 2680.0105571 0.60 3.22
ag2a Not found
ag2g2 2179.46 261.51 257.73 2179.83 265.39 2680.0056265 3.69 6.31
g2g1g1 243.64 68.84 89.11 2178.25 253.86 2680.0107768 1.82 3.08
g2g1a 270.69 70.03 173.74 177.69 260.93 2680.013685 0.00 1.25
g2g1g2 Not found
g2ag1 281.05 2170.72 82.04 2176.20 256.70 2680.0113096 1.49 2.74
g2aa 286.80 2175.44 159.35 177.50 261.92 2680.0118794 1.13 2.39
g2ag2 281.58 2169.72 266.09 178.07 268.29 2680.0074812 3.89 5.15
g2g2g1 271.25 281.96 64.31 177.19 262.61 2680.0118537 1.15 2.40
g2g2a 275.46 270.88 144.73 175.96 259.04 2680.0124754 0.76 2.01
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Table 5
Computed conformational characteristics of the (R)-2-methyl-3-mercapto-propanamide optimised at HF/3-21G level of theory
u f c v x Etotal DE DDE
g1g1g1 59.62 54.85 56.78 179.12 64.63 2680.0077715 3.71 4.96
g1g1a 75.46 70.88 2144.73 2175.96 59.04 2680.0124754 0.76 2.01
g1g1g2 71.24 81.89 264.46 2177.07 62.42 2680.0118538 1.15 2.40
g1ag1 81.75 169.72 66.10 2178.03 68.19 2680.0074814 3.89 5.15
g1aa 86.80 175.44 2159.35 2177.50 61.92 2680.0118794 1.13 2.39
g1ag2 81.05 170.72 282.77 176.21 56.72 2680.0113095 1.49 2.74
g1g2g1 Not found
g1g2a 70.57 270.11 2173.72 2177.63 61.04 2680.0136855 0.00 1.25
g1g2g2 43.64 268.84 289.11 178.25 53.86 2680.0107768 1.83 3.08
ag1g1 179.46 61.49 57.67 179.87 65.42 2680.0056264 3.69 6.31
ag1a Not found
ag1g2 2162.42 89.84 253.79 179.12 64.44 2680.0105571 0.60 3.22
aag1 2167.67 172.23 65.53 2177.61 67.04 2680.0071222 2.75 5.37
aaa 2175.46 172.88 2164.66 2177.59 59.84 2680.0115057 0.00 2.62
aag2 178.94 178.94 282.57 176.34 53.19 2680.0103653 0.72 3.34
ag2g1 158.71 283.27 47.96 2178.89 62.74 2680.0074613 2.54 5.16
ag2a Not found
ag2g2 2179.15 260.34 267.24 2179.15 58.16 2680.0072888 2.65 5.27
g2g1g1 267.17 60.69 51.17 2174.96 64.34 2680.0078444 4.92 4.92
g2g1a 275.82 68.03 2164.42 2176.67 60.54 2680.0156812 0.00 0.00
g2g1g2 Not found
g2ag1 268.95 170.46 63.92 2177.96 64.23 2680.0089084 4.25 4.25
g2aa 272.75 174.08 2164.51 2178.44 58.36 2680.0123034 2.12 2.12
g2ag2 268.76 173.93 285.69 176.52 52.14 2680.0109917 2.94 2.94
g2g2g1 277.18 277.25 59.64 177.16 62.88 2680.0086255 4.43 4.43
g2g2a 299.88 268.03 174.57 2178.75 56.18 2680.0088266 4.30 4.30
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therefore along the variablec the amino acid back-
bone may only have three conformers (gL, eL andaL)
rather than the usual nine. This work has already been
published [10]. However, there are additional compli-
cations. The nitrogen in proline has two alkyl group
attached therefore one would expect similar energies
to cis- andtrans-peptide bonds in any proline residue
[6]. This is in direct contrast to all naturally occurring
amino acids. The problem has already been presented
at the Fifth World Congress at WATOC [12] and
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The process ofcis–trans isomerism may also be
important in the docking of captopril. Clearly one
would expect a different separation between the two
negatively charged terminii.






























































































Fig. 5. Computed conformational energies,DE (kcal/mol) of 2-methyl-3-mercapto-propanamide.
Obviously,dtrans represents a longer separation and
dcis a shorter separation. It may be anticipated that the
separation (dACE) of the two points at the active site of
the ACE cannot be shorter or larger thatdcis anddtrans,
respectively:
dcis , dACE , dtrans
In this sense captopril may be regarded to be a
molecular “calliper” in establishing certain structural
features of the ACE. Ab initio computations on the
captopril, as a whole, has to wait until more comput-
ing power becomes available.
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